ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDEN Eden Research Plc

4.25
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.25 4.00 4.50 4.25 4.25 4.25 255,065 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.12 22.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.25p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £22.67 million. Eden Research has a price to earnings ratio (PE ratio) of -10.12.

Eden Research Share Discussion Threads

Showing 8201 to 8219 of 17900 messages
Chat Pages: Latest  332  331  330  329  328  327  326  325  324  323  322  321  Older
DateSubjectAuthorDiscuss
27/6/2020
17:53
Poster showing the key mergers and acquisitions that have occurred in the seed industry since 2000
supersonico
26/6/2020
18:44
Remember that fella who said Eden would become a big player in the biopesticide space.. and you thought... .well that's good, it's definitely growing but still pretty small by conventional standards.

Well have a look at this conclusion and then reconsider that statement with this in mind.


'Biologicals will replace a large portion of chemical crop-protection products and fertilizers, which together represent a market exceeding $240 billion. Biologicals will control pests, diseases, and weeds and fertilize crops directly all without harming beneficials, which in turn compounds their effectiveness. The widespread use of biologicals will revolutionize agriculture by triggering a resurgence in the residential beneficial populations that will control pests and diseases and make crops more resilient against biotic and abiotic crop stresses (e.g., heat, drought, and salinity during climate change) while increasing crop health and yields.

Stakeholders at every level will benefit from this revolution: Consumers will be assured that their food is grown safely and sustainably; farmers will have new tools for regenerative agriculture and a new income stream from sustainable services such as carbon sequestration as a means to combat climate change; and the industry will enjoy a large new market, which will guarantee a sustainable pipeline of future biologicals, thus more than replacing revenues lost due to declining chemical usage'.

supersonico
26/6/2020
18:33
Hello SuperIf what you say is correct than it is quite disappointing that the share price hasn't shifted a gear.Until recently it was Artemis who held the share price back by selling in the market. Wonder who the new seller is?it's a pity that share register of major shareholders was last updated on 24/3/20 on Eden's website. Enjoy the weekend
northwick
26/6/2020
18:13
Investing,
Looks like under the radar stake building to me.
Similar amount of trades per day,
Then occasional days with none or very few.

There was relatively little uptick in buying from the roadshows
This is patient buying from wise folk who have a decent idea of the news timeline game that Eden are weaving.

supersonico
26/6/2020
16:00
Eden Research advanced 8 per cent to 8p after being granted two important patents for its Sustaine technology, which consists of biodegradable micro-spheres derived from yeast extract, in the US.
spurslegend1
26/6/2020
15:36
Anyone else surprised by this run of small buys in Eden?
investingisatrickygame
26/6/2020
11:41
Today I asked Eden about which Patents the US Patent RNS refers.
supersonico
26/6/2020
08:24
Good find Northwick,

I don't think Doctors were qualified or paid to give dietary advice;)

supersonico
26/6/2020
08:16
'Not what the doctor ordered': Microplastics found in fruit and veg - Sky Newshttps://apple.news/AdpVxkP_kRbGrZlJmwPMKig
northwick
26/6/2020
08:12
https://apple.news/AdpVxkP_kRbGrZlJmwPMKig
northwick
25/6/2020
15:52
A dark evil walks amongst us ..news

Another big pay out to the victims of intentional corporate damage from another company that says it's product is still safe..and still we trust them..LOL

Women With Cancer Awarded Billions in Baby Powder Suit
An appellate court in Missouri upheld more than $2 billion in damages against Johnson & Johnson, saying the company knew there was asbestos in its baby powder.

supersonico
25/6/2020
14:38
Super, I know it’s a patent aproval.Let’s say I was just being a bit cheeky using the word “product”; ; after all, we all know now that it’s not a matter of if, but when Mevalone, Cedroz, seeds treatment with Sustaine, etc, will start entering the US market. Actually, Cedroz has already been approved in Mexico, wich is a big US exporter... ;)
sortudo7
25/6/2020
13:41
Sortudo7,

The RNS is about Patents(not product approvals) which they are choosing not to detail in the release... Why????????????

So that means to me ..it's either two new patents yet to be disclosed or two patents already obvious to anyone with Google so already publicly known.

This is ground working for a future announcement or two imo that they have not prepared us for due to NDA's.. that's why the last two RNS'S tell us nothing.

As with most things Eden, it's sweets for the Swedish kiddies until it's not.

supersonico
25/6/2020
13:22
Interesting to see the US approval of Eden’s products after my last week post regarding to the bees genocide/ disappearance in the States. Coincidence?
sortudo7
25/6/2020
08:42
Or.. more likely imho .. like the recent Bayer RNS were seeing the Ivor Barry narrative warm up for the parallel delayed CAP/TT Bayer/Dow announcement.

The last Patent RNS prior to todays was 2014... The first ever Bayer RNS was 2020.

supersonico
25/6/2020
07:38
Could be a game changer. Or more jam tomorrow. With Eden's track record I would put my money on the latter.
grahamg8
24/6/2020
23:17
Super,

Whilst some of my submitted questions were answered, I would have like to have had others addressed, specifically in regards to Sustaine which is central to Eden's future success.

Maybe other shareholders have commentary on questions they may have submitted?

investingisatrickygame
24/6/2020
19:57
Thanks Mj,

That's an embarrassingly short list of warm Werthers butter mint cuddly grandad comfort questions we roughly knew the answer to already or knew they would be relatively giant numbers compared to all else Eden sell. All that was missing was the Labrador in a cardigan.

I particularly enjoyed the blatant CAP/TT dodge.

Parallel delay still in play I have little doubt.

AWGATWT.

supersonico
24/6/2020
19:25
Annual General Meeting 2020 – Q&A
mirandaj
Chat Pages: Latest  332  331  330  329  328  327  326  325  324  323  322  321  Older

Your Recent History

Delayed Upgrade Clock